The Microfluidic Biomolecular team is developing an integrated microfluidic system for simple and robust biomolecular amplification with an inexpensive reader to conduct a rapid and complicated analysis of a range of samples encountered in the field. They are targeting this microfluidic biomolecular amplification reader (MicroBAR) at global health diagnostics, with a specific focus on tuberculosis detection and classification based on drug resistant genotype. Funds will be used to return to South Africa to scale up their project for field deployment.
Development of a simple prognostic test for rheumatic heart disease (UC Berkeley)
We aim to develop a simple prognostic tool for rheumatic heart disease. In the first phase of the project we aim to identify a set
August 7, 2009
